Skip to contentE
Electromedical Technologies, Inc
E
EMEDElectromedical Technologies, Inc Q3 2024 · 10-Q
Revenue$42.53K$42.53K−86.9% vs Q3 2023 Net Income-$724.64K-$724.64KN/M vs Q3 2023 EPS, diluted—
Gross Profit$30,645−87.8% Operating Income-$381,038N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Electromedical Technologies, Inc · CIK 1715819 · Engraved from SEC EDGAR
Operating Cash Flowderived-$30,829N/M Margins · derivedGross margin72.1%−5.6 pt vs Q3 2023
Operating margin-896.0%−822.1 pt vs Q3 2023
Net margin-1704.0%−1587.6 pt vs Q3 2023
ended Sep 30, 2024 · filed Nov 19, 2024 · 50 d after period end